{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:55:48Z","timestamp":1781607348985,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Isr J Health Policy Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Telepharmacy, the use of telecommunications technology to facilitate pharmacy services, has emerged as an integral component of telehealth, particularly during the COVID-19 pandemic. In Israel, the shortage of pharmacists nationwide has led to longer wait times and reduced consultation opportunities at community pharmacies. In response, the Pharmaceutical Society of Israel (PSI) established a telepharmacy call center to provide free pharmaceutical consultations to the public. This study aimed to describe the framework of this center, the types of pharmaceutical consultations and patient satisfaction with the service.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional observational study analyzed unidentified data from 1,542 ambulatory patient inquiries to the PSI telepharmacy call center between October 2022 and June 2023. The consultations were categorized into clinical, logistical, and patient rights-related inquiries. A satisfaction survey was conducted among a representative sample of callers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The majority of inquiries (93.3%) were received via telephone, with the 65\u201385 age group accounting for 38.4% of callers. A small proportion of inquiries were submitted via email, either exclusively or in combination with a telephone communication. Clinical inquiries comprised 89% of the total, with the most common topics being drug interactions (26.7%), general drug usage guidance (17.8%), and inquiries about drug side effects (16.4%). The patient satisfaction survey revealed that 87% of respondents strongly agreed that the pharmacists demonstrated empathy and attentiveness, and 93.5% were satisfied with the responses provided. The overall service rating was 8.9 out of 10, and 94.1% of respondents were willing to recommend the call center to others.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights the value and feasibility of operating a national telepharmacy call center in Israel, addressing the diverse pharmaceutical needs of the public, particularly the elderly population. The high satisfaction levels among callers underscore the potential for such initiatives to enhance access to comprehensive pharmaceutical consultation and improve medication management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13584-025-00686-4","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T07:38:58Z","timestamp":1746085138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing medication literacy through a telepharmacy call center in Israel: consultation overview and patient satisfaction"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6757-8630","authenticated-orcid":false,"given":"Ran","family":"Nissan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Hurgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hen","family":"Popilski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaleel","family":"Zahalka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merav Ben","family":"Natan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Schwartzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"686_CR1","unstructured":"Telepharmacy. Guidelines. Ottawa (ON). Canadian Society of Hospital Pharmacists; 2018."},{"issue":"7","key":"686_CR2","first-page":"327","volume":"55","author":"S Baldoni","year":"2019","unstructured":"Baldoni S, Amenta F, Ricci G. Telepharmacy services: present status and future perspectives: A review. Med (Kaunas). 2019;55(7):327.","journal-title":"Med (Kaunas)"},{"issue":"19","key":"686_CR3","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1093\/ajhp\/zxac188","volume":"79","author":"BR Begnoche","year":"2022","unstructured":"Begnoche BR, David Butler C, Carson PH, Darr A, Jenkins MT, Le T, McDaniel RB, Mourad H, Shipman CJ, Stratton TP, Tran K, Wong KK. ASHP statement on telehealth pharmacy practice. Am J Health Syst Pharm. 2022;79(19):1728\u201335.","journal-title":"Am J Health Syst Pharm"},{"key":"686_CR4","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.2147\/JMDH.S343528","volume":"14","author":"L Margusino-Frami\u00f1\u00e1n","year":"2021","unstructured":"Margusino-Frami\u00f1\u00e1n L, Fern\u00e1ndez-Llamazares CM, Negro-Vega E, Tortajada-Goitia B, Lizeaga G, Mercadal-Orfila G, Almeida-Gonz\u00e1lez C, Morillo-Verdugo R. Outpatients\u2019 opinion and experience regarding telepharmacy during the COVID-19 pandemic: the enopex project. J Multidiscip Healthc. 2021;14:3621\u201332.","journal-title":"J Multidiscip Healthc"},{"issue":"4","key":"686_CR5","first-page":"183","volume":"9","author":"EJ Unni","year":"2021","unstructured":"Unni EJ, Patel K, Beazer IR, Hung M. Telepharmacy during COVID-19: A scoping review. Pharm (Basel). 2021;9(4):183.","journal-title":"Pharm (Basel)"},{"issue":"2","key":"686_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1089\/tmj.2021.0575","volume":"29","author":"TV Dat","year":"2023","unstructured":"Dat TV, Tu VL, Quan NK, Minh NH, Trung TD, Le TN, Phuc-Vinh D, Trinh DT, Pham Dinh L, Nguyen-Thi HY, Huy NT. Telepharmacy: A systematic review of field application, benefits, limitations, and applicability during the COVID-19 pandemic. Telemed J E Health. 2023;29(2):209\u201321.","journal-title":"Telemed J E Health"},{"issue":"3","key":"686_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/00185787211032360","volume":"57","author":"C Liu","year":"2022","unstructured":"Liu C, Patel K, Cernero B, Baratt Y, Dandan N, Marshall O, Li H, Efird L. Expansion of pharmacy services during COVID-19: pharmacists and pharmacy extenders filling the gaps through telehealth services. Hosp Pharm. 2022;57(3):349\u201354.","journal-title":"Hosp Pharm"},{"issue":"9","key":"686_CR8","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1089\/tmj.2021.0420","volume":"28","author":"E Hefti","year":"2022","unstructured":"Hefti E, Wei B, Engelen K. Access to telepharmacy services May reduce hospital admissions in outpatient populations during the COVID-19 pandemic. Telemed J E Health. 2022;28(9):1324\u201331.","journal-title":"Telemed J E Health"},{"key":"686_CR9","unstructured":"Manpower in the Healthcare Professions as of 2021, Israel (Hebrew). Israeli Ministry of Health. 2023. Available at: https:\/\/www.gov.il\/he\/departments\/publications\/reports\/health-professions-manpower"},{"key":"686_CR10","unstructured":"Ministry of Health, Pharmacy Division. - Improving pharmacist service to the patient, standards for pharmacy services and Tele Pharmacy - position paper for comments, May 29, 2019 (https:\/\/www.health.gov.il\/hozer\/dr_471089219.pdf)."},{"key":"686_CR11","unstructured":"The Israeli Society. for Patients\u2019 Rights website. https:\/\/www.patients-rights.org\/en\/about-us?form_submit=1"},{"issue":"4","key":"686_CR12","first-page":"109","volume":"6","author":"XY Lim","year":"2018","unstructured":"Lim XY, Yeo QQ, Kng GLL, Chung WL, Yap KZ. Validation of a Drug-Related problem classification system for the intermediate and Long-Term care setting in Singapore. Pharm (Basel). 2018;6(4):109.","journal-title":"Pharm (Basel)"},{"key":"686_CR13","unstructured":"Pharmacy Quality Alliance (PQA). Medication Therapy Problem Categories Framework for PQA Measures document for a framework of MRPs and detailed description of categories and rationale. Available from http:\/\/www.pqaalliance.org\/images\/uploads\/files\/PQA MTP Categories Framework.pdf."},{"key":"686_CR14","doi-asserted-by":"crossref","unstructured":"Greg\u00f3rio J, Cavaco AM, Lap\u00e3o LV. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis. Res Social Adm Pharm 2017 Jan-Feb;13(1):133\u201347.","DOI":"10.1016\/j.sapharm.2016.02.008"},{"key":"686_CR15","doi-asserted-by":"crossref","unstructured":"Bednarczyk RA, Nadeau JA, Davis CF, McCarthy A, Hussain S, Martiniano R, Lodise T, Zeolla MM, Coles FB, McNutt LA. Privacy in the pharmacy environment: analysis of observations from inside the pharmacy. J Am Pharm Assoc (2003). 2010 May-Jun;50(3):362-7.","DOI":"10.1331\/JAPhA.2010.09001"},{"issue":"4","key":"686_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/03630240802575054","volume":"48","author":"DA Rier","year":"2008","unstructured":"Rier DA, Schwartzbaum A, Heller C. Methodological issues in studying an insular, traditional population: a women\u2019s health survey among Israeli haredi (ultra-Orthodox) Jews. Women Health. 2008;48(4):363\u201381.","journal-title":"Women Health"},{"issue":"6","key":"686_CR17","doi-asserted-by":"publisher","first-page":"e205873","DOI":"10.1001\/jamanetworkopen.2020.5873","volume":"3","author":"ME Reed","year":"2020","unstructured":"Reed ME, Huang J, Graetz I, Lee C, Muelly E, Kennedy C, Kim E. Patient characteristics associated with choosing a telemedicine visit vs office visit with the same primary care clinicians. JAMA Netw Open. 2020;3(6):e205873.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"686_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12911-022-01834-5","volume":"22","author":"K Moulaei","year":"2022","unstructured":"Moulaei K, Shanbehzadeh M, Bahaadinbeigy K, Kazemi-Arpanahi H. Survey of the patients\u2019 perspectives and preferences in adopting telepharmacy versus in-person visits to the pharmacy: a feasibility study during the COVID-19 pandemic. BMC Med Inf Decis Mak. 2022;22(1):99.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"1","key":"686_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/ijpp.12109","volume":"23","author":"I Ho","year":"2015","unstructured":"Ho I, Nielsen L, Jacobsgaard H, Salmasi H, Potteg\u00e5rd A. Chat-based telepharmacy in Denmark: design and early results. Int J Pharm Pract. 2015;23(1):61\u20136.","journal-title":"Int J Pharm Pract"},{"issue":"3","key":"686_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/17151635211006446","volume":"154","author":"L Gu\u00e9nette","year":"2021","unstructured":"Gu\u00e9nette L, Chagnon A, Turcotte V. User experience with the ask your pharmacist teleconsultation platform. Can Pharm J (Ott). 2021;154(3):213\u201321.","journal-title":"Can Pharm J (Ott)"},{"issue":"4","key":"686_CR21","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.amjmed.2020.12.008","volume":"134","author":"MS McFarland","year":"2021","unstructured":"McFarland MS, Buck ML, Crannage E, Armistead LT, Ourth H, Finks SW, McClurg MR, writing on behalf of the Get the Medications Right Institute. Assessing the impact of comprehensive medication management on achievement of the quadruple aim. Am J Med. 2021;134(4):456\u201361.","journal-title":"Am J Med"},{"issue":"2","key":"686_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1353\/hpu.2021.0102","volume":"32","author":"S Pathak","year":"2021","unstructured":"Pathak S, Blanchard CM, Moreton E, Urick BY. A systematic review of the effect of telepharmacy services in the community pharmacy setting on care quality and patient safety. J Health Care Poor Underserved. 2021;32(2):737\u201350.","journal-title":"J Health Care Poor Underserved"},{"key":"686_CR23","doi-asserted-by":"crossref","unstructured":"Le T, Toscani M, Colaizzi J, Telepharmacy. A new paradigm for our profession. J Pharm Pract. 2020;33(2):176\u201382.","DOI":"10.1177\/0897190018791060"},{"key":"686_CR24","doi-asserted-by":"crossref","unstructured":"Park JY, Zed PJ, Vera MA. Perspectives and experiences with telepharmacy among pharmacists in Canada: A cross-sectional survey. Pharm Pract (Granada). 2022 Jan-Mar;20(1):2609.","DOI":"10.18549\/PharmPract.2022.1.2609"},{"issue":"1","key":"686_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13584-018-0251-y","volume":"7","author":"E Schwartzberg","year":"2018","unstructured":"Schwartzberg E, Nathan JP, Avron S, Marom E. Clinical and other specialty services offered by pharmacists in the community: the international arena and Israel. Isr J Health Policy Res. 2018;7(1):59.","journal-title":"Isr J Health Policy Res"},{"key":"686_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/DHPS.S283708","volume":"13","author":"V Milos Nymberg","year":"2021","unstructured":"Milos Nymberg V, Lenander C, Borgstr\u00f6m Bolmsj\u00f6 B. The impact of medication reviews conducted in primary care on hospital admissions and mortality: an observational Follow-Up of a randomized controlled trial. Drug Healthc Patient Saf. 2021;13:1\u20139.","journal-title":"Drug Healthc Patient Saf"},{"issue":"5","key":"686_CR27","doi-asserted-by":"publisher","first-page":"e1002798","DOI":"10.1371\/journal.pmed.1002798","volume":"16","author":"S Verdoorn","year":"2019","unstructured":"Verdoorn S, Kwint HF, Blom JW, Gussekloo J, Bouvy ML. Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-study). PLoS Med. 2019;16(5):e1002798.","journal-title":"PLoS Med"}],"updated-by":[{"DOI":"10.1186\/s13584-026-00760-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000}}],"container-title":["Israel Journal of Health Policy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13584-025-00686-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13584-025-00686-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13584-025-00686-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:22:40Z","timestamp":1781605360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13584-025-00686-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["686"],"URL":"https:\/\/doi.org\/10.1186\/s13584-025-00686-4","relation":{},"ISSN":["2045-4015"],"issn-type":[{"value":"2045-4015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13584-026-00760-5","URL":"https:\/\/doi.org\/10.1186\/s13584-026-00760-5","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since no identifying information was available to the researchers, there was no need in receiving any type of informed consent. In addition, this study received approval from the Hillel Yaffe Medical Center Institutional Review Board (#HYMC-0122-23). All methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research was not supported by funding. All authors approve that they do not have any financial and personal relationships with other people, or organizations, that could inappropriately influence (bias) this research and this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}],"article-number":"26"}}